CAESARSTONE LTD (CSTE) Fundamental Analysis & Valuation

NASDAQ:CSTE • IL0011259137

Current stock price

1.65 USD
+0.03 (+1.85%)
At close:
1.73 USD
+0.08 (+4.85%)
After Hours:

This CSTE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. CSTE Profitability Analysis

1.1 Basic Checks

  • CSTE had negative earnings in the past year.
  • CSTE had a negative operating cash flow in the past year.
  • CSTE had negative earnings in 4 of the past 5 years.
  • In multiple years CSTE reported negative operating cash flow during the last 5 years.
CSTE Yearly Net Income VS EBIT VS OCF VS FCFCSTE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M

1.2 Ratios

  • CSTE's Return On Assets of -34.53% is on the low side compared to the rest of the industry. CSTE is outperformed by 90.48% of its industry peers.
  • CSTE has a worse Return On Equity (-95.01%) than 88.10% of its industry peers.
Industry RankSector Rank
ROA -34.53%
ROE -95.01%
ROIC N/A
ROA(3y)-20.1%
ROA(5y)-13.14%
ROE(3y)-47.61%
ROE(5y)-30.48%
ROIC(3y)N/A
ROIC(5y)N/A
CSTE Yearly ROA, ROE, ROICCSTE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60 -80

1.3 Margins

  • CSTE's Gross Margin of 18.45% is on the low side compared to the rest of the industry. CSTE is outperformed by 76.19% of its industry peers.
  • CSTE's Gross Margin has declined in the last couple of years.
  • CSTE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.45%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.91%
GM growth 5Y-7.69%
CSTE Yearly Profit, Operating, Gross MarginsCSTE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. CSTE Health Analysis

2.1 Basic Checks

  • CSTE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • CSTE has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, CSTE has more shares outstanding
  • The debt/assets ratio for CSTE has been reduced compared to a year ago.
CSTE Yearly Shares OutstandingCSTE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
CSTE Yearly Total Debt VS Total AssetsCSTE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • Based on the Altman-Z score of 1.14, we must say that CSTE is in the distress zone and has some risk of bankruptcy.
  • CSTE has a Altman-Z score of 1.14. This is amonst the worse of the industry: CSTE underperforms 88.10% of its industry peers.
  • CSTE has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of CSTE (0.00) is better than 92.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.14
ROIC/WACCN/A
WACC8.31%
CSTE Yearly LT Debt VS Equity VS FCFCSTE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

2.3 Liquidity

  • CSTE has a Current Ratio of 1.83. This is a normal value and indicates that CSTE is financially healthy and should not expect problems in meeting its short term obligations.
  • CSTE has a Current ratio (1.83) which is in line with its industry peers.
  • CSTE has a Quick Ratio of 1.15. This is a normal value and indicates that CSTE is financially healthy and should not expect problems in meeting its short term obligations.
  • CSTE's Quick ratio of 1.15 is in line compared to the rest of the industry. CSTE outperforms 50.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.83
Quick Ratio 1.15
CSTE Yearly Current Assets VS Current LiabilitesCSTE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. CSTE Growth Analysis

3.1 Past

  • CSTE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -74.42%.
  • CSTE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -10.38%.
  • Measured over the past years, CSTE shows a decrease in Revenue. The Revenue has been decreasing by -3.97% on average per year.
EPS 1Y (TTM)-74.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-37.14%
Revenue 1Y (TTM)-10.38%
Revenue growth 3Y-16.84%
Revenue growth 5Y-3.97%
Sales Q2Q%-3.5%

3.2 Future

  • CSTE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.07% yearly.
  • The Revenue is expected to grow by 2.21% on average over the next years.
EPS Next Y32%
EPS Next 2Y22.07%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.59%
Revenue Next 2Y2.21%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CSTE Yearly Revenue VS EstimatesCSTE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
CSTE Yearly EPS VS EstimatesCSTE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2

More info and screens

Find the best growth stocksShow best growing peers

1

4. CSTE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CSTE. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CSTE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CSTE Price Earnings VS Forward Price EarningsCSTE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CSTE Per share dataCSTE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • CSTE's earnings are expected to grow with 22.07% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.07%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CSTE Dividend Analysis

5.1 Amount

  • No dividends for CSTE!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CSTE Fundamentals: All Metrics, Ratios and Statistics

CAESARSTONE LTD

NASDAQ:CSTE (4/17/2026, 8:04:03 PM)

After market: 1.73 +0.08 (+4.85%)

1.65

+0.03 (+1.85%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)03-04
Earnings (Next)05-05
Inst Owners12.53%
Inst Owner Change0%
Ins Owners3.76%
Ins Owner Change0%
Market Cap57.06M
Revenue(TTM)397.23M
Net Income(TTM)-137.57M
Analysts82.86
Price Target4.08 (147.27%)
Short Float %3.39%
Short Ratio0.5
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-29.53%
Min EPS beat(2)-35.23%
Max EPS beat(2)-23.84%
EPS beat(4)1
Avg EPS beat(4)-31.91%
Min EPS beat(4)-79.74%
Max EPS beat(4)11.15%
EPS beat(8)3
Avg EPS beat(8)-23.7%
EPS beat(12)3
Avg EPS beat(12)-218.49%
EPS beat(16)4
Avg EPS beat(16)-180.02%
Revenue beat(2)1
Avg Revenue beat(2)0.69%
Min Revenue beat(2)-1.19%
Max Revenue beat(2)2.57%
Revenue beat(4)2
Avg Revenue beat(4)-1.31%
Min Revenue beat(4)-7.26%
Max Revenue beat(4)2.57%
Revenue beat(8)2
Avg Revenue beat(8)-4.4%
Revenue beat(12)3
Avg Revenue beat(12)-5.46%
Revenue beat(16)3
Avg Revenue beat(16)-4.83%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.14
P/FCF N/A
P/OCF N/A
P/B 0.39
P/tB 0.39
EV/EBITDA N/A
EPS(TTM)-1.5
EYN/A
EPS(NY)-1.02
Fwd EYN/A
FCF(TTM)-1.36
FCFYN/A
OCF(TTM)-1.1
OCFYN/A
SpS11.49
BVpS4.19
TBVpS4.19
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -34.53%
ROE -95.01%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.45%
FCFM N/A
ROA(3y)-20.1%
ROA(5y)-13.14%
ROE(3y)-47.61%
ROE(5y)-30.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.91%
GM growth 5Y-7.69%
F-Score3
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 63.64%
Cap/Sales 2.27%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.83
Quick Ratio 1.15
Altman-Z 1.14
F-Score3
WACC8.31%
ROIC/WACCN/A
Cap/Depr(3y)53.89%
Cap/Depr(5y)59.94%
Cap/Sales(3y)2.2%
Cap/Sales(5y)2.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-74.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-37.14%
EPS Next Y32%
EPS Next 2Y22.07%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-10.38%
Revenue growth 3Y-16.84%
Revenue growth 5Y-3.97%
Sales Q2Q%-3.5%
Revenue Next Year1.59%
Revenue Next 2Y2.21%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-52.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year75.29%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-319.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-219.31%
OCF growth 3YN/A
OCF growth 5YN/A

CAESARSTONE LTD / CSTE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CAESARSTONE LTD (CSTE) stock?

ChartMill assigns a fundamental rating of 2 / 10 to CSTE.


Can you provide the valuation status for CAESARSTONE LTD?

ChartMill assigns a valuation rating of 1 / 10 to CAESARSTONE LTD (CSTE). This can be considered as Overvalued.


How profitable is CAESARSTONE LTD (CSTE) stock?

CAESARSTONE LTD (CSTE) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for CSTE stock?

The Earnings per Share (EPS) of CAESARSTONE LTD (CSTE) is expected to grow by 32% in the next year.